← Open Payments lookup

MICHAEL TREISMAN: Open Payments

NPI 1184685455 · FLORISSANT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$760 in 40 payments from 13 companies in 2025. Trend: 2023 $779 · 2024 $696 · 2025 $760

Food & beverage: $760
CompanyPaymentsAmount
ABBVIE INC.14$220
AstraZeneca Pharmaceuticals LP4$143
GlaxoSmithKline, LLC.5$88
Lilly USA, LLC3$58
Novo Nordisk Inc3$56
Amgen Inc.2$39
Sumitomo Pharma America, Inc.2$35
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$32
Medtronic, Inc.1$20
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20

Products named: FARXIGA, QULIPTA, TRELEGY ELLIPTA, UBRELVY, AIRSUPRA, VRAYLAR, EVENITY, MOUNJARO.

Industry payments across MO — which companies pay providers there.